查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929658

全球周邊血分離管市場（按產品、技術、應用和最終用戶分類）預測（2026-2032年）

Peripheral Blood Separation Tube Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年外周血分離管市場價值為 8.1412 億美元，預計到 2026 年將成長至 8.7502 億美元，預計到 2032 年將達到 12.7693 億美元，複合年成長率為 6.64%。

主要市場統計數據
基準年 2025 8.1412億美元
預計年份：2026年 8.7502億美元
預測年份：2032年 1,276,930,000 美元
複合年成長率 (%) 6.64%

本文簡要概述了影響周邊血分離管生態系的臨床意義、技術進步和運作重要性。

周邊血分離管是臨床診斷、輸血醫學和轉化研究中的基礎工具，是連接病患檢體和下游檢測流程的橋樑。這些分離管能夠高效分離血漿、血清和細胞成分，同時保持分析物的完整性，適用於從常規血液學檢測到先進細胞治療流程的各種應用。隨著臨床通訊協定向更高通量和靈敏度發展，分離管的設計和性能特徵，包括抗凝血劑的化學性質、分離技術和材料相容性，都成為決定診斷準確性和操作效率的關鍵因素。

臨床需求、先進分離技術和供應鏈韌性的融合如何重塑產品預期和策略夥伴關係

由於臨床、技術和操作因素的共同作用，周邊血液分離管領域正經歷變革性的轉變。分離技術的進步，包括密度梯度分離、凝膠分離、膜分離系統和微流體平台，使得細胞分級分離的精確控制和生物標記保存的改善成為可能，從而促進了精準診斷和細胞療法的廣泛應用。隨著檢查室追求更高的自動化等級和更有效率的工作流程，分離管必須具備穩定可靠的自動化性能和嚴格的公差，最大限度地減少人工操作時間，並降低分析前誤差。

評估2025年美國累積關稅對該領域採購、製造本地化和採購韌性的系統性和營運性影響

2025年實施的累積關稅標誌著周邊血分離管價值鏈的籌資策略、製造地和定價趨勢發生了關鍵性轉變。進口關稅的提高增加了從受影響地區採購的某些原料和成品組件的到岸成本，迫使採購者重新評估總擁有成本（TCO），而不僅僅依賴單價比較。因此，採購團隊在選擇供應商時會考慮關稅風險，並加強對原產地聲明和關稅分類的審查，以減少意外成本轉嫁。

將終端用戶畫像、抗凝劑類型、應用、分離技術和分銷管道與採購創新優先事項聯繫起來的詳細細分分析

這項富有洞察力的細分分析揭示了臨床環境、產品形式、應用、技術和分銷管道的差異如何影響周邊血分離管的需求特徵和實施重點。終端用戶群十分多元化。血庫包括私人和公共機構，它們優先考慮高通量處理和標準化，以確保輸血安全。診斷實驗室分為兩類：一類是優先考慮臨床工作流程和電子健康記錄整合的醫院檢查室，另一類是優先考慮吞吐量和成本效益的獨立檢查室。醫院包括診所、二級醫院和三級醫院，每家醫院的檢測項目和後勤限制各不相同。就地檢驗中心既運作行動檢測車，也運作固定檢測中心，因此需要能夠承受各種環境條件並實現快速處理的試管。研究機構涵蓋從學術實驗室到製藥研發機構等各種類型，它們通常需要特殊的抗凝劑配方和分離技術，以保持細胞表現型和功能，從而進行高級檢測。

美洲、歐洲、中東、非洲和亞太地區監管嚴格程度、供應鏈策略和臨床應用趨勢的觀點比較分析

區域趨勢對周邊血分離管的調節管道、供應鏈結構和臨床應用模式有顯著影響。在美洲，臨床基​​礎設施的特點是擁有完善的醫院系統、廣泛的實驗室網路，並高度重視法規遵循和可追溯性。這種環境有利於那些具有可靠驗證包裝、與自動化平台相容且供應持續穩定的解決方案。採購團隊優先考慮具有國內或區域生產能力的供應商，以最大限度地減少海關手續的複雜性，並支援大規模醫院系統和血庫的快速補貨。

透過創新、監管能力和強大的生產基地實現差異化，以滿足多樣化的臨床和研究需求。

周邊血分離管領域的主要企業透過產品創新、嚴格的法規遵循和整合的供應鏈能力實現差異化競爭。市場參與企業涵蓋了從跨國診斷和耗材製造商到專業利基生產商和契約製造組織 (CMO) 等各類企業，後者支援定製配方和自有品牌生產。競爭優勢通常來自於將檢驗的品管生產能力與快速反應的技術支援和完善的上市後監管措施相結合。

在瞬息萬變的醫療保健市場中，製造商和經銷商可以採取哪些切實可行的策略步驟來增強產品差異化、供應鏈韌性和監管應對力？

在瞬息萬變的市場環境中，產業領導者可以採取一系列切實可行的措施來鞏固市場地位、提升產品價值並降低營運風險。首先，應優先考慮產品檢驗，並將其與臨床工作流程和自動化測試系統結合。嚴格的性能演示和互通性測試將降低產品推廣門檻，並有助於提升產品高階定位。其次，應增加對靈活製造和區域生產基地的投資，以減輕貿易中斷的影響並滿足區域監管要求。此外，還應制定清晰的品質系統協調計劃，並在必要時進行重新認證。

整合永續競爭的策略要求：重點檢驗的臨床價值、營運靈活性和監管合規性

周邊血分離管在實驗室操作、臨床決策和轉化研究的交會點佔據著至關重要的地位。技術創新、臨床工作流程的改變以及不斷發展的貿易和法規環境的共同作用，正推動分析前設備從普通商品躍升為診斷和治療領域的戰略資產。醫療機構的選擇標準也日益嚴格，優先考慮那些擁有檢驗的性能、監管能力和供應鏈韌性的供應商。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的周邊血分離管市場

  • ACD管
    • ACD-A管
    • ACD-B管
  • 檸檬酸管
    • 檸檬酸鈉管
    • 檸檬酸三鈉管
  • EDTA管
    • K2 EDTA管
    • K3 EDTA管
  • 肝素管
    • 鋰肝素管
    • 肝素鈉管
  • 草酸管
    • 草酸鉀管
    • 草酸鈉管

9. 依技術分類的周邊血分離管市場

  • 密度梯度離心
  • 凝膠分離管
  • 膜分離管
  • 微流體分離

第10章 依應用分類的周邊血液分離管市場

  • 血庫
  • 細胞療法
  • 臨床診斷
  • 研究

第11章 依最終用戶分類的外周血分離管市場

  • 血庫
    • 私人血庫
    • 公共血庫
  • 診斷實驗室
    • 醫院檢查室
    • 獨立檢驗機構
  • 醫院
    • 診所
    • 二級護理醫院
    • 三級醫院
  • 就地檢驗中心
    • 移動式偵測單元
    • 現場測試中心
  • 研究所
    • 學術研究
    • 藥物研究

第12章 周邊血分離管市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 周邊血分離管市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國外周血分離管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 美國周邊血分離管市場

第17章 中國外周血分離管市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma
  • Becton, Dickinson & Company
  • Biosigma SpA
  • Cardinal Health, Inc.
  • CML BIOTECH LIMITED
  • FL Medical SRL
  • Greiner Bio-One International GmbH
  • Haemonetics Corporation
  • Medtronic plc
  • Merck KGaA
  • Narang Medical Limited
  • Nipro Medical Corporation
  • QIAGEN NV
  • SARSTEDT AG & Co. KG
  • Sekisui Chemical Co., Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-0A3806951875

The Peripheral Blood Separation Tube Market was valued at USD 814.12 million in 2025 and is projected to grow to USD 875.02 million in 2026, with a CAGR of 6.64%, reaching USD 1,276.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 814.12 million
Estimated Year [2026] USD 875.02 million
Forecast Year [2032] USD 1,276.93 million
CAGR (%) 6.64%

A concise orientation to clinical relevance, technological evolution, and operational imperatives shaping the peripheral blood separation tube ecosystem

Peripheral blood separation tubes are foundational tools in clinical diagnostics, transfusion medicine, and translational research, serving as the interface between patient samples and downstream laboratory processes. These tubes facilitate efficient separation of plasma, serum, and cellular components while preserving analyte integrity for a broad range of applications from routine hematology to advanced cell therapy workflows. As clinical protocols evolve toward higher throughput and greater sensitivity, the design and performance characteristics of separation tubes-such as anticoagulant chemistry, separator technologies, and material compatibility-have become critical determinants of diagnostic fidelity and operational efficiency.

The contemporary landscape favors products that reduce pre-analytical variability, enhance sample stability, and integrate with automated systems. This creates pressure on suppliers to align manufacturing quality, regulatory documentation, and product portfolios with the increasingly rigorous needs of hospitals, reference laboratories, and research institutions. Concurrently, innovation in microfluidics and membrane-based separators is broadening the functional envelope of tubes, enabling more granular cell isolation and point-of-care workflows that previously required specialized instrumentation.

Against this backdrop, stakeholders must navigate shifting reimbursement environments, evolving regulatory expectations around labeling and biocompatibility, and the practical realities of global supply chains. The interplay of these elements shapes procurement criteria, informs product development roadmaps, and drives collaborations between clinical end users and manufacturers seeking to differentiate through validated performance and operational value.

How converging clinical demands, advanced separation technologies, and supply chain resilience are reshaping product expectations and strategic partnerships

The peripheral blood separation tube sector is undergoing transformative shifts driven by converging clinical, technological, and operational forces. Advances in separation technologies such as density gradient methods, gel-based separators, membrane systems, and microfluidic platforms are enabling finer control over cell fractionation and improved preservation of biomarkers, which in turn supports the rise of precision diagnostics and cell-based therapeutics. As laboratories pursue higher automation and leaner workflows, tubes must deliver consistent, automation-friendly performance and tighter tolerances to minimize hands-on time and reduce pre-analytical errors.

Clinical trends are reinforcing demand for robust pre-analytics: decentralized testing and point-of-care diagnostics are expanding the contexts in which tubes must perform reliably, while research and cell therapy applications require specialized anticoagulants and separation chemistries to maintain cell viability and functional integrity. These needs are accentuated by regulatory frameworks that increasingly emphasize traceability, material safety, and validation evidence, prompting manufacturers to invest in enhanced documentation and quality management systems.

Operationally, supply chain resilience and geographic diversification of production have become strategic priorities. Procurement teams are prioritizing suppliers with validated manufacturing controls, redundant sourcing, and transparent quality systems. Innovation ecosystems are also evolving, with collaborations between device makers, reagent suppliers, and clinical partners accelerating product iterations that address niche use cases, such as mobile testing units and pharmacological research applications. In sum, the landscape is shifting from commodity-driven procurement toward solution-oriented partnerships that emphasize validated performance, regulatory readiness, and supply continuity.

Assessment of the systemic and operational consequences of 2025 cumulative US tariffs on sourcing, manufacturing localization, and procurement resilience in the sector

The imposition of cumulative tariffs in the United States during 2025 has created a material inflection point for procurement strategies, manufacturing footprints, and pricing dynamics in the peripheral blood separation tube value chain. Increased import duties have elevated the landed cost of certain raw materials and finished components sourced from affected jurisdictions, prompting buyers to reassess total cost of ownership rather than relying solely on unit price comparisons. Consequently, procurement teams are factoring in tariff exposure when qualifying suppliers and are increasing scrutiny of origin declarations and tariff classifications to mitigate unexpected cost pass-throughs.

Manufacturers and contract producers have responded with a mix of tactical and strategic actions. Tactically, many have adjusted SKU mixes, negotiated alternative supplier contracts, and implemented cost-avoidance measures in procurement and logistics to absorb near-term tariff impacts without sacrificing quality. Strategically, several firms have accelerated localization plans, shifting critical production steps closer to key end markets or investing in regional manufacturing capabilities to reduce dependency on tariff-exposed supply lines. These investments improve responsiveness to demand variability and reduce vulnerability to future trade policy shifts, though they require capital, time, and regulatory re-certification efforts.

The tariffs have also influenced innovation trajectories. Developers are prioritizing material substitutions and design optimizations that maintain performance while reducing reliance on tariff-sensitive inputs. In parallel, end users have begun to factor tariff-induced lead-time variability into inventory policies and to consider longer procurement cycles with safety stock for essential consumables. Overall, the cumulative effect has been a rebalancing of cost, quality, and delivery considerations, with an emphasis on resilient sourcing, transparent supplier relationships, and product continuity under evolving trade conditions.

Detailed segmentation analysis connecting end-user profiles, anticoagulant types, applications, separation technologies, and distribution pathways to purchasing and innovation priorities

Insightful segmentation helps clarify how different clinical settings, product formats, applications, technologies, and distribution pathways shape demand characteristics and adoption priorities for peripheral blood separation tubes. End users vary widely: blood banks encompass private and public institutions that prioritize high-volume, standardized processing for transfusion safety, while diagnostic laboratories are split between hospital-based labs, which value integration with clinical workflows and electronic health records, and independent labs, which emphasize throughput and cost efficiency. Hospitals include clinics, secondary care hospitals, and tertiary care hospitals, each with distinct testing portfolios and logistical constraints. Point-of-care testing centers operate in both mobile testing units and on-site testing centers, requiring tubes that withstand varied environmental conditions and enable rapid processing. Research institutes span academic labs and pharmaceutical research facilities, often demanding specialized anticoagulant formulations and separator technologies to preserve cell phenotype and functionality for advanced assays.

Product-type differentiation is equally consequential: anticoagulant chemistries such as ACD, citrate, EDTA, heparin, and oxalate are chosen based on downstream analytical requirements and cell viability considerations. ACD variants, including ACD-A and ACD-B, are frequently specified for cell preservation in banking and therapy contexts, whereas citrate options like sodium citrate and trisodium citrate are selected when coagulation parameters are critical. EDTA in its K2 and K3 forms remains a mainstay for hematology due to its ability to chelate calcium without significantly altering cell morphology. Heparin tubes, available as lithium or sodium heparin, are favored for certain biochemical assays and for preserving cell function in operational workflows. Oxalate-based tubes, including potassium and sodium oxalate, remain relevant for specialized coagulation and biochemical testing where enzyme stability is a concern.

Application-driven needs further refine product selection: blood banking prioritizes donor safety and long-term stability, cell therapy requires formulations and separators that maintain viability and sterility, clinical diagnostics demand compatibility with analytic platforms and minimal pre-analytical variability, and research applications often need custom or small-batch solutions that support experimental protocols. Technological differentiation also plays a role: density gradient centrifugation is prized for its established role in mononuclear cell isolation, gel separator tubes provide simplified plasma/serum separation for routine testing, membrane separators offer selective filtering for targeted fractionation, and emerging microfluidic separation enables low-volume, high-precision isolation suitable for point-of-care and research contexts.

Distribution channels complete the segmentation picture by influencing procurement lead times, pricing models, and customer support expectations. Direct sales relationships are frequently preferred by large institutional buyers seeking contract terms and technical support, whereas distributors-operating through retailers and wholesalers-enable broader geographic reach and inventory coverage. Online retail, split between company websites and e-marketplaces, serves smaller buyers and enables rapid replenishment cycles. Each channel imposes different expectations around documentation, traceability, and post-sale service, which in turn affect supplier selection and product packaging decisions.

Comparative regional perspectives on regulatory rigor, supply chain strategies, and clinical adoption trends across the Americas, EMEA, and Asia-Pacific environments

Regional dynamics significantly influence regulatory pathways, supply chain architectures, and clinical adoption patterns for peripheral blood separation tubes. In the Americas, clinical infrastructures are characterized by advanced hospital systems, extensive laboratory networks, and a strong emphasis on regulatory compliance and traceability. This environment favors solutions with robust validation packages, compatibility with automated platforms, and supply continuity assurances. Procurement teams prioritize vendors with domestic or regional manufacturing capabilities to minimize customs complexity and to support rapid replenishment for large hospital systems and blood banks.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory regimes and healthcare capacities vary considerably. Western and parts of Northern Europe feature stringent regulatory oversight, well-established diagnostics networks, and a premium on product safety and environmental compliance. In contrast, regions across the Middle East and Africa often prioritize cost-effective, durable solutions that can tolerate wider logistical and environmental variability, while simultaneously encouraging local capacity building. For manufacturers, this region requires adaptable market strategies that combine compliance documentation for high-regulation markets with resilient distribution models for areas with limited cold-chain or logistical infrastructure.

Asia-Pacific encompasses a mix of mature markets with strong R&D ecosystems and high-volume manufacturing hubs, as well as rapidly developing healthcare systems experiencing growth in diagnostic capacity and translational research. Demand drivers in this region include investments in hospital modernization, expansion of point-of-care testing, and increased focus on cell therapy research. Manufacturers often leverage regional production capabilities to serve both domestic markets and export-oriented supply chains, while navigating diverse regulatory requirements and local preference for cost-competitive solutions. Across all regions, end users emphasize supply predictability, validated performance, and post-market support, but the weighting of these priorities shifts according to regional healthcare structures and procurement norms.

Corporate differentiation through innovation, regulatory competency, and resilient manufacturing footprints that support varied clinical and research demands

Leading companies in the peripheral blood separation tube domain are differentiating through product innovation, regulatory rigor, and integrated supply chain capabilities. Market participants range from multinational diagnostic and consumables manufacturers to specialized niche producers and contract manufacturing organizations that support tailored formulations and private-label production. The competitive edge often arises from the ability to combine validated, quality-managed manufacturing with responsive technical support and strong post-market surveillance practices.

Innovation pathways are clustered around anticoagulant chemistry optimization, separator material science, and platform compatibility. Firms investing in R&D to deliver microfluidic-enabled separation or enhanced membrane technologies can address emerging use cases such as low-volume point-of-care diagnostics and delicate cell therapy workflows. Equally important is regulatory competence: companies with established processes for device classification, biocompatibility testing, and clinical performance validation reduce adoption friction for institutional buyers. Strategic partnerships with clinical laboratories, research institutes, and automated instrument vendors also accelerate product validation and market acceptance.

Manufacturing footprint and supply chain architecture are further differentiators. Vendors with geographically diversified production and robust quality systems can better support large healthcare systems and blood banks that require reliable supply continuity. At the same time, contract manufacturers that offer small-batch flexibility and rapid development services enable researchers and niche clinical segments to access tailored solutions. Service and support capabilities-ranging from product training to troubleshooting for integration with robotic systems-reinforce customer retention and create opportunities for value-added offerings such as custom packaging, lot-level certificates, and inventory management programs.

Practical strategic steps for manufacturers and distributors to boost product differentiation, supply resilience, and regulatory readiness in a dynamic healthcare market

Industry leaders can adopt a set of actionable approaches to strengthen market position, enhance product value, and mitigate operational risks in a rapidly evolving environment. First, prioritize product validation that aligns with clinical workflows and automated laboratory systems; rigorous performance evidence and interoperability testing reduce adoption barriers and support premium positioning. Second, invest in flexible manufacturing and regional production nodes to reduce exposure to trade disruptions and to meet localized regulatory requirements; this approach should be coupled with a clear plan for quality system alignment and re-certification where necessary.

Third, pursue targeted innovation that addresses unmet needs such as low-volume microfluidic separation for point-of-care use, or anticoagulant formulations optimized for cell therapy and biologic research. These innovations should be developed in partnership with end users-blood banks, hospital labs, point-of-care centers, and research institutions-to accelerate validation and ensure practical utility. Fourth, strengthen supplier transparency and tariff-risk management by implementing traceability protocols for raw materials and by engaging in forward-looking sourcing agreements that include contingency clauses and alternative supplier networks.

Fifth, enhance commercial models by offering bundled services-technical onboarding, inventory management, and customized documentation-to institutional customers that require predictable supply and regulatory support. Finally, embed sustainability and waste-reduction practices into product design and packaging to meet growing environmental expectations from healthcare procurement organizations and to differentiate on corporate responsibility dimensions.

This research synthesizes primary and secondary methodologies to generate rigorous, actionable insights on peripheral blood separation tubes. Primary research incorporated structured interviews and validation discussions with a cross-section of stakeholders, including clinical laboratory directors, blood bank managers, procurement specialists, research scientists, and technical leads at manufacturing and distribution firms. These engagements focused on use-case requirements, procurement decision drivers, operational pain points, and preferences for product attributes such as anticoagulant chemistry, separator type, and compatibility with automation.

Secondary research included a systematic review of peer-reviewed literature, regulatory guidance documents, manufacturer technical data sheets, and clinical procedure standards to triangulate product performance characteristics and regulatory expectations. Where applicable, public filings and quality system documentation were used to corroborate manufacturing capabilities and compliance practices. Data synthesis emphasized qualitative validation and trend identification rather than numerical estimation, ensuring that conclusions reflect practical constraints and emergent industry behaviors.

Analytical frameworks employed include segmentation mapping by end user, product type, application, technology, and distribution channel, along with supply chain risk matrices and regulatory readiness assessments. Findings were validated through an iterative process of expert review and cross-referencing with clinical practice patterns to ensure relevance and applicability for strategic decision-making.

Synthesis of strategic imperatives emphasizing validated clinical value, operational agility, and regulatory alignment for sustainable competitiveness

Peripheral blood separation tubes occupy a pivotal position at the intersection of laboratory operations, clinical decision-making, and translational research. The combined pressures of technological innovation, changing clinical workflows, and evolving trade and regulatory environments have elevated pre-analytical devices from commodity status to strategic assets in diagnostic and therapeutic pathways. Institutions are increasingly selective, favoring suppliers that demonstrate validated performance, regulatory competence, and supply chain resilience.

Looking across end users, product formats, and technologies, it is evident that differentiation will come from delivering demonstrable clinical value, enabling automation, and supporting specialized applications such as cell therapy and decentralized testing. Operational agility-manifested through regional manufacturing, transparent sourcing, and robust post-market support-will be a key determinant of long-term supplier credibility. Firms that align product development with documented clinical needs and that invest in partnerships for validation are likely to secure preferential procurement from hospitals, diagnostic labs, blood banks, point-of-care centers, and research institutes.

In conclusion, the trajectory for peripheral blood separation tubes favors quality-driven innovation and strategic supply management. Organizations that proactively address regulatory compliance, clinical integration, and tariff-related supply vulnerabilities will be better positioned to capture the strategic value of this essential pre-analytical category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Blood Separation Tube Market, by Product Type

  • 8.1. ACD Tubes
    • 8.1.1. ACD-A Tubes
    • 8.1.2. ACD-B Tubes
  • 8.2. Citrate Tubes
    • 8.2.1. Sodium Citrate Tubes
    • 8.2.2. Trisodium Citrate Tubes
  • 8.3. Edta Tubes
    • 8.3.1. K2 Edta Tubes
    • 8.3.2. K3 Edta Tubes
  • 8.4. Heparin Tubes
    • 8.4.1. Lithium Heparin Tubes
    • 8.4.2. Sodium Heparin Tubes
  • 8.5. Oxalate Tubes
    • 8.5.1. Potassium Oxalate Tubes
    • 8.5.2. Sodium Oxalate Tubes

9. Peripheral Blood Separation Tube Market, by Technology

  • 9.1. Density Gradient Centrifugation
  • 9.2. Gel Separator Tubes
  • 9.3. Membrane Separator Tubes
  • 9.4. Microfluidic Separation

10. Peripheral Blood Separation Tube Market, by Application

  • 10.1. Blood Banking
  • 10.2. Cell Therapy
  • 10.3. Clinical Diagnostics
  • 10.4. Research

11. Peripheral Blood Separation Tube Market, by End User

  • 11.1. Blood Banks
    • 11.1.1. Private Blood Banks
    • 11.1.2. Public Blood Banks
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Hospital-Based Labs
    • 11.2.2. Independent Labs
  • 11.3. Hospitals
    • 11.3.1. Clinics
    • 11.3.2. Secondary Care Hospitals
    • 11.3.3. Tertiary Care Hospitals
  • 11.4. Point-Of-Care Testing Centers
    • 11.4.1. Mobile Testing Units
    • 11.4.2. On-Site Testing Centers
  • 11.5. Research Institutes
    • 11.5.1. Academic Research
    • 11.5.2. Pharma Research

12. Peripheral Blood Separation Tube Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peripheral Blood Separation Tube Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peripheral Blood Separation Tube Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peripheral Blood Separation Tube Market

16. China Peripheral Blood Separation Tube Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AdvaCare Pharma
  • 17.6. Becton, Dickinson & Company
  • 17.7. Biosigma S.p.A.
  • 17.8. Cardinal Health, Inc.
  • 17.9. CML BIOTECH LIMITED
  • 17.10. FL Medical S.R.L.
  • 17.11. Greiner Bio-One International GmbH
  • 17.12. Haemonetics Corporation
  • 17.13. Medtronic plc
  • 17.14. Merck KGaA
  • 17.15. Narang Medical Limited
  • 17.16. Nipro Medical Corporation
  • 17.17. QIAGEN N.V.
  • 17.18. SARSTEDT AG & Co. KG
  • 17.19. Sekisui Chemical Co., Ltd.
  • 17.20. Terumo Corporation
  • 17.21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-A TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-A TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-A TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-B TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-B TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-B TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM CITRATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM CITRATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM CITRATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TRISODIUM CITRATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TRISODIUM CITRATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TRISODIUM CITRATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K2 EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K2 EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K2 EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K3 EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K3 EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K3 EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POTASSIUM OXALATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POTASSIUM OXALATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POTASSIUM OXALATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM OXALATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM OXALATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM OXALATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GEL SEPARATOR TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GEL SEPARATOR TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GEL SEPARATOR TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MEMBRANE SEPARATOR TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MEMBRANE SEPARATOR TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MEMBRANE SEPARATOR TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MICROFLUIDIC SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MICROFLUIDIC SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MICROFLUIDIC SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRIVATE BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRIVATE BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PUBLIC BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PUBLIC BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITAL-BASED LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITAL-BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITAL-BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MOBILE TESTING UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MOBILE TESTING UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MOBILE TESTING UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ON-SITE TESTING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ON-SITE TESTING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ON-SITE TESTING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PHARMA RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PHARMA RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PHARMA RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 273. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 274. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 275. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 277. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 282. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBE